PPF81 Case report: subcutaneous ertapenem and temocillin for symptom control of pelvic collection in the palliative care setting

Read full text Summarise with VIRAT
Authors: Oliver Maynard, Christopher Nobbs
Cited by: 0
References: 3

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction Infections are common in patients with life-limiting diseases, and can significantly impact quality-of-life. However, there is limited evidence for the use of antibiotics for symptom control, despite emerging evidence that antibiotics may help patients who are receiving palliative care. Drug administration can be challenging in the palliative setting due to often compromised enteral routes and problems of access and place of care raised by intravenous medications. But, with expanding pharmacokinetic evidence the subcutaneous route has been proven to be an effective way of delivering several antibiotics. Method We present the case of a female in her fifties with an incurable presacral collection secondary to a rectosigmoid junction adenocarcinoma who presented to the specialist palliative inpatient unit with fevers, pain, and purulent rectal discharge. Initial pharmacological and non-pharmacological interventions were unsuccessful at adequately controlling these symptoms Results In turn, subcutaneous Ertapenem then Temocillin were successful in reducing fevers, pain and volume of the purulent discharge. Subcutaneous antibiotic infusions were tolerated well after adjustments to the infusion rate. The patient had a significant improvement in her quality-of-life and was able to spend greater than four months at home and complete important life events. Here we provide the infusion preparation and administration regimes that were successfully utilised. Conclusion Using antibiotics by the subcutaneous route obviated the need for hospital admission and avoided harm from repeated intravenous access attempts. This case raises the question whether the use of subcutaneous antibiotics for symptom control should be more common. However, the decision to use antibiotics in patients with life-limiting diseases is individualised and must always be weighed against the risk of side effects, and the potential to escalate the growth of resistant bacteria.

Fields of Study & Subjects

Palliative and Oncologic Care Palliative Care and End-of-Life Issues Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
BMJ Supportive & Palliative Care
Pages
A74.3–A75
Publication date
25 March 2026
Language
EN